Haemonetics | HAE - 销售成本



金融业
股票价格
USD
资产
USD 2.4B
现金及等价物
USD 245.44M
销售成本
USD 136.58M
流动资产
USD 834.88M
流动负债
USD 282.6M
债务
USD 1.22B
EBIT
USD 67.4M
EBITDA
USD 94.78M
员工
3.02K
EPS每股收益
USD 1.29
股本和储备
USD 796.32M
销售毛利
USD 202.39M
债务利息支出
USD 7.4M
利息收入
USD 6.96M
贷款资金
USD 1.22B
市值
USD 3.4B
净收入
USD 44.74M
营业费用
USD 134.99M
营业利润
USD 67.4M
普通股股本
USD 46.83M
PE价格收益
18.49
税前利润
USD 59.98M
销售收入
USD 346M
销售和管理费用
USD 109.15M
股票
USD 306.37M
贸易债权人
USD 51.06M
应收帐款人
USD 195.71M


销售成本 更改 日
Avanos Medical USD 88M 6.9M 2026-03
Baxter International USD 1.81B 587M 2026-03
Becton, Dickinson and Co. USD 2.56B 281M 2026-03
Boston Scientific USD 1.83B 8M 2026-03
Cerus USD 23.42M 3.61M 2024-12
Cooper Companies USD 376.8M 87.4M 2025-12
Fresenius EUR 4.45B 262M 2025-12
Fresenius Medical Care EUR 3.43B 248M 2026-03
Globus Medical USD 263.59M 26.88M 2026-03
Haemonetics USD 136.58M 4.01M 2025-12
ICU Medical USD 337.72M 1.61M 2025-12
Intuitive Surgical USD 940.3M 21.6M 2026-03
Masimo USD 152.8M 12.4M 2026-03
Medtronic USD 3.61B 83M 2025-12
Merit Medical Systems USD 197.08M 1.5M 2026-03
Neogen USD 112.2M 5.81M 2025-12
OraSure Technologies USD 15.43M 113K 2025-12
Quidel USD -79.5M 528.3M 2026-03
ResMed USD 551.67M 4.17M 2026-03
STAAR Surgical USD 24.66M 10.6M 2026-03
Steris USD 891.3M 50.6M 2026-03
Stryker USD 2.36B 325M 2026-03
Surmodics USD 9.49M 23.54M 2025-06
Teleflex USD 240.84M 20.7M 2026-03
Terumo JPY 151.3B 7.86B 2026-03
Thermo Fisher Scientific USD 6.96B 620M 2026-03
US Physical Therapy USD 163.6M 2.74M 2026-03
Zimmer Biomet Holdings USD 738.3M 231.8M 2026-03